3121638
Last Update Posted: 2017-04-20
Recruiting has ended
All Genders accepted | 20 Years + |
150 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Safety Study of NBP608 in Healthy Adult Volunteers
Indication: Protection against varicella and herpes zoster
Study Objectives
- Primary: Safety and tolerability assessment after single dose administration of NBP608
- Secondary: immunogenicity assessment after single dose administration of NBP608
This is a single-center, open label, active controlled, dose-escalation, parallel group study to assess the safety, tolerability and immunogenicity of NBP608 in healthy adult volunteers. Total of 150 healthy subjects aged 20 and over are enrolled, and each subject is administered with single dose of vaccine which is sequentially assigned to active group 1, 2 and study group 1~3 in 1:1:1:1:1 ratio(30 subjects are enrolled at each groups) .
Eligibility
Relevant conditions:
Varicella Zoster
Immunization; Infection
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov